Skip to main content
Clinical Trials/DRKS00023442
DRKS00023442
Recruiting
Not Applicable

Registry for neonates, infants, children, adolescents,and adults with newly diagnosed and/or relapsedneuroblastic tumors(NB Registry 2016) - NB Registry 2016

K Köln0 sites5,000 target enrollmentNovember 4, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C74.1
Sponsor
K Köln
Enrollment
5000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2020
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
K Köln

Eligibility Criteria

Inclusion Criteria

  • Diagnosis or suspicion of neuroblastic tumor in patients either histologically or cytologically proven neuroblastic tumors such as neuroblastoma, ganglioneuroblastoma, and ganglioneuroma (at diagnosis or at
  • relapse), also suspected neuroblastoma in newborns and infants (e.g. suprarenal lesions) detected at least during two independent ultrasound investigations, any age, any stage, any MYCN status, written Guardians’ informed consent of parents or legal guardians and / or of the patient’s informed consent if appropriate according to age and status of psycho\-intellectual development.

Exclusion Criteria

  • For this registry, no exclusion criteria are defined. Each patient meeting the inclusion criteria given above may be registered.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Suspended
Not Applicable
Registry for children, adolescents and adults with Osteosarcoma and biologically related bone sarcomas (COSS-Registry)Malignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-likenon-conventional: telangiectatic, small cell, high-grade surface), periosteal, parosteal, extra-skeletal, low-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma
DRKS00027990Klinikum der Landeshauptstadt Stuttgart gKAöRZentrum für Kinder-, Jugend- und Frauenmedizin Standort Mitte (Olgahospital) Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)Cooperative Osteosarkom Studiengruppe (COSS)1,000
Not yet recruiting
Not Applicable
Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancyPregnancyCOVID-19 infectionReproductive Health and Childbirth - Childbirth and postnatal careReproductive Health and Childbirth - Complications of newbornReproductive Health and Childbirth - Fetal medicine and complications of pregnancyInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseases
ACTRN12620000449932niversity of Melbourne200
Recruiting
Not Applicable
Mother and Baby Health registryHealth Condition 1: O269- Pregnancy related conditions, unspecified
CTRI/2023/09/057557Eunice Kennedy Shriver National Institute of Child Health and Human Development
Recruiting
Not Applicable
Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19)U07.1COVID-19, virus identified
DRKS00021506niversitätsklinikum Carl Gustav Carus1,000
Not yet recruiting
Not Applicable
Breast Milk vs. Sucrose as Analgesia for Painful Procedures in the Neonatal Unit
ACTRN12611000268943Waitakere Hospital100